Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

Viral Infections, Non-HIV

Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison

J Infect

Baro B, Rodo P, Ouchi D, Bordoy AE, Saya Amaro EN, Salsench SV, Molinos S, Alemany A, Ubals M, Corbacho-Monné M, Millat-Martinez P, Marks M, Clotet B, Prat N, Ara J, Vall-Mayans M, G-Beiras C, Bassat Q, Blanco I, Mitjà O

doi: 10.1016/j.jinf.2021.04.009

Viral Infections, Non-HIV

Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation

J Clin Virol.

Jääskeläinen AJ, Kuivanen S, Kekäläinen E, Ahava MJ, Loginov R, Kallio-Kokko H, Vapalahti O, Jarva H, Kurkela S, Lappalainen M

doi: 10.1016/j.jcv.2020.104512.

Viral Infections, Non-HIV

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

N Engl J Med.

van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ

doi: 10.1056/NEJMc2004973.

Viral Infections, Non-HIV

Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)

J Clin Virol.

Nicol T, Lefeuvre C, Serri O, Pivert A, Joubaud F, Dubée V, Kouatchet A, Ducancelle A, Lunel-Fabiani F, Le Guillou-Guillemette H

doi: 10.1016/j.jcv.2020.104511.

Viral Infections, Non-HIV

Validation of a commercially available SARS-CoV-2 serological immunoassay

Clin Microbiol Infect.

Meyer B, Torriani G, Yerly S, Mazza L, Calame A, Arm-Vernez I, Zimmer G, Agoritsas T, Stirnemann J, Spechbach H, Guessous I, Stringhini S, Pugin J, Roux-Lombard P, Fontao L, Siegrist CA, Eckerle I, Vuilleumier N, Kaiser L, Geneva Center for Emerging Viral Diseases.

doi: 10.1016/j.cmi.2020.06.024.

Viral Infections, Non-HIV

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Viruses.

Ahmed SF, Quadeer AA, McKay MR

doi: 10.3390/v12030254.

Viral Infections, Non-HIV

Persistence of anti-sars-cov-2 antibodies: immunoassay heterogeneity and implications for serosurveillance

Clin Microbiol Infect

Perez-Saez J, Zaballa ME, Yerly S, Andrey DO, Meyer B, Eckerle I, Balavoine JF, Chappuis F, Pittet D, Trono D, Kherad O, Vuilleumier N, Kaiser L, Guessous I, Stringhini S, Azman AS, Specchio-COVID19 Study Group.

doi: 10.1016/j.cmi.2021.06.040

Viral Infections, Non-HIV

Comparison and Application of Different Immunoassay Methods for the Detection of SARS-CoV-2

J Med Virol.

He J, Hu P, Gao Y, Zheng S, Xu C, Liu R, Fang L, Li R, Han C, An J, Dong J, Deng G, Sun L, Lv Y

doi: 10.1002/jmv.26187.

Viral Infections, Non-HIV

Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study

Lancet Respir Med.

Pallett SJC, Rayment M, Patel A, Fitzgerald-Smith SAM, Denny SJ, Charani E, Mai AL, Gilmour KC, Hatcher J, Scott C, Randell P, Mughal N, Jones R, Moore LSP, Davies GW

doi: 10.1016/S2213-2600(20)30315-5.

Related content

Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison

Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)

Validation of a commercially available SARS-CoV-2 serological immunoassay

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Persistence of anti-sars-cov-2 antibodies: immunoassay heterogeneity and implications for serosurveillance

Comparison and Application of Different Immunoassay Methods for the Detection of SARS-CoV-2

Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study